ENVERIC
LIVE

Serial Number

97520334

Owner

ENVERIC BIOSCIENCES, INC.

Attorney

Richard M. Klein

First Use Date

Nov 17, 2022

Filing Date

Jul 26, 2022

Add to watchlist:

No watchlists yet
View on USPTO

ENVERIC Trademark

Serial Number: 97520334 • Registration: 7186904

ENVERIC is a trademark filed by ENVERIC BIOSCIENCES, INC. on July 26, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

ENVERIC BIOSCIENCES, INC. (6 trademarks)

4851 TAMIAMI TRAIL N
NAPLES, FL 34103

Entity Type: 03

Trademark Details

Filing Date

July 26, 2022

Registration Date

October 10, 2023

First Use Anywhere

November 17, 2022

First Use in Commerce

November 17, 2022

Published for Opposition

July 25, 2023

Goods & Services

pharmaceutical substances for use in the prevention, treatment and management of cancer, pain, mental health disorders, cancer related distress, anxiety, depression and post-traumatic stress disorder; pharmaceutical substances for use in the management of side effects from chemotherapy, radiation therapy, immunotherapy, and cancer treatment; Anti-cancer preparations; Pharmaceutical products for the treatment of cancer

pharmaceutical research services; medical research services; medical research laboratory services; research and development of new products for others; research and development services, for the development of a portfolio of psychoactive compounds and derivatives targeted for the treatment of medical conditions and disorders; research and development services, for the development of a portfolio of compounds and derivatives targeted for the treatment of cancer and the side effects of cancer; providing online non-downloadable computer software for data analytics, machine learning, knowledge management, and predictive analysis of biostatistical data and treatment data, in the field of medical research; scientific and technological research services in the fields of medicine, biotechnology, and pharmaceuticals; scientific and technological research and drug development in the fields of cancer, pain, mental health disorders, cancer related distress, anxiety, depression and post-traumatic stress disorder; product development of pharmaceutical substances and medicines; pharmaceutical testing services; scientific laboratory services; research laboratory services relating to pharmaceuticals

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 31, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 31, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 31, 2025 REAP
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Oct 10, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Oct 10, 2023 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 25, 2023 NPUB
PUBLISHED FOR OPPOSITION
Jul 25, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 5, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 22, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 21, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 20, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 20, 2023 TROA
NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
May 16, 2023 AAUA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 13, 2023 GNRN
NON-FINAL ACTION E-MAILED
May 13, 2023 GNRT
NON-FINAL ACTION WRITTEN
May 13, 2023 CNRT
USE AMENDMENT ACCEPTED
May 13, 2023 IUAA
ASSIGNED TO EXAMINER
May 11, 2023 DOCK
AMENDMENT TO USE PROCESSING COMPLETE
Jan 19, 2023 AUPC
USE AMENDMENT FILED
Jan 19, 2023 IUAF
TEAS AMENDMENT OF USE RECEIVED
Jan 18, 2023 EAAU
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 17, 2022 NWOS
NEW APPLICATION ENTERED
Jul 29, 2022 NWAP